Fortress Biotech (FBIO)
Sources, funds and advances drug assets through a portfolio-company network.
$2.42
vs last close+0.01 (+0.41%)
Something off on this page? Send us feedback.
Next report
Nov 16, 26
in 55 days
EPS estimate
−$0.27
Revenue estimate
$21.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.26−$0.48−$0.46$0.11−$0.21$2.82−$0.08Pending
Estimate−$0.79−$0.44−$0.31−$0.43$0.42−$0.22−$0.20−$0.27
Surprise+67.1%−9.1%−48.4%+125.6%−150.0%+1,381.8%+60.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$15.1M$13.1M$16.4M$17.6M$16.1M$16.0M$18.7MPending
Estimate$14.6M$11.6M$21.0M$21.0M$26.2M$16.3M$18.3M$21.6M
Surprise+3.7%+13.1%−21.9%−16.1%−38.5%−1.8%+2.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$0.25 | — | — |
| Nov 2026 | −$0.27 | — | — |
| Aug 2026 | −$0.20 | −$0.08 | +60.0% |
| May 2026 | −$0.22 | $2.82 | +1,381.8% |
| Mar 2026 | $0.42 | −$0.21 | −150.0% |
| Nov 2025 | −$0.43 | $0.11 | +125.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$0.25 | — | — | $22.5M | — | — | — |
| Nov 16, 2026 | −$0.27 | — | — | $21.6M | — | — | — |
| Aug 13, 2026 | −$0.20 | −$0.08 | +60.0% | $18.3M | $18.7M | +2.3% | +8.4% |
| May 14, 2026 | −$0.22 | $2.82 | +1,381.8% | $16.3M | $16.0M | −1.8% | +4.8% |
| Mar 31, 2026 | $0.42 | −$0.21 | −150.0% | $26.2M | $16.1M | −38.5% | −11.5% |
| Nov 14, 2025 | −$0.43 | $0.11 | +125.6% | $21.0M | $17.6M | −16.1% | +5.2% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 16, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 16, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 15, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |